Our schedules are seriously crowded these days, whether it be running from clinic to clinic, squeezing in lunch meetings, or trying to run errands after work, by the time we arrive at home we are too mentally exhausted to do...
Our schedules are seriously crowded these days, whether it be running from clinic to clinic, squeezing in lunch meetings, or trying to run errands after work, by the time we arrive at home we are too mentally exhausted to do...
The author shares the story of an extraordinary father and son, two of the major figures in defining the specialty of ophthalmology as we know it today. The renowned Glasgow Surgeon Peter Lowe described ophthalmic surgery in his legendary surgical...
Swansea University invited me to an Away Day. There was a whole day of lectures planned at a hotel conference suite just outside Swansea but due to clinic commitments I only caught the afternoon session; a ‘workshop’, on how to...
History A 69-year-old female patient was referred to the uveitis clinic from her local district general hospital with a left posterior uveitis which had been unresponsive to high dose steroids. She had no other previous ophthalmic history nor significant systems...
Syringocystadenoma papilliferum (SP) is an exceedingly rare, benign adnexal tumour primarily affecting the skin. It is characterised by the presence of cystic structures and papillary projections. This uncommon dermatological condition is typically found in areas rich in apocrine glands, such...
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.
Patients with the eye condition Paracentral Acute Middle Maculopathy (PAMM) would benefit from further investigation, as their risk of heart attacks and strokes may be greater than previously shown, suggests a new study led by researchers at Moorfields Eye Hospital NHS Foundation Trust.
A “pioneering” BCLA global consensus report will deliver evidence-based guidance to eyecare professionals on all aspects of presbyopia and its management – shaping the future of patient care for years to come.
Glaucoma UK is a leading charity dedicated to supporting those affected by glaucoma. The charity is proud to announce the establishment of the Pitts Crick Career Development Fellowship, a three-year post-doctoral research fellowship awarded to help mark the charity’s golden jubilee anniversary. The fellowship will support a rising star within glaucoma research, who the charity hopes will go on to play a pivotal role in transforming glaucoma diagnosis or treatment into the future.